<> GlaxoSmithKline Pharmaceuticals Share Price Today: Live GlaxoSmithKline Pharmaceuticals Share Price NSE/BSE | 5paisa
GLAXO

Glaxosmithkline Pharmaceuticals Share PriceGlaxoSmithKline Pharmaceuticals

₹1269.6
6.6 (0.52%)
  • Advice
  • Hold
As on 30 January, 2023 | 10:55 BSE: 500660 NSE: GLAXO

Glaxosmithkline Pharmaceuticals Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in GlaxoSmithKline Pharmaceuticals

Start SIP

Glaxosmithkline Pharmaceuticals Share Price

  • Over 1 Month -4.57%
  • Over 3 Month -7.05%
  • Over 6 Month -12.53%
  • Over 1 Year -22.5%

Glaxosmithkline Pharmaceuticals Key Statistics

P/E Ratio 12.8
PEG Ratio 0.1
Market Cap Cr 21,508
Price to Book Ratio 8.1
EPS 99.2
Dividend 7.1
Relative Strength Index 27.09
Money Flow Index 44.34
MACD Signal -11.18
Average True Range 17.52

Glaxosmithkline Pharmaceuticals Investment Rating

  • Master Rating:
  • Glaxosmithkline Pharms. has an operating revenue of Rs. 3,287.52 Cr. on a trailing 12-month basis. An annual revenue growth of 10% is good, Pre-tax margin of 24% is great, ROE of 63% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 64 which is a FAIR score but needs to improve its earnings, a RS Rating of 26 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D which indicates heavy supply, Group Rank of 118 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

GlaxoSmithKline Pharmaceuticals Financials
IndicatorSep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 906729792
Operating Expenses Qtr Cr 649582619
Operating Profit Qtr Cr 257148173
Depreciation Qtr Cr 161615
Interest Qtr Cr 010
Tax Qtr Cr 6944262
Net Profit Qtr Cr 1941191,218

Glaxosmithkline Pharmaceuticals Technicals

EMA & SMA

Current Price
₹1269.5
6.5 (0.51%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 16
  • 20 Day
  • 1295.67
  • 50 Day
  • 1318.31
  • 100 Day
  • 1353.28
  • 200 Day
  • 1410.52
  • 20 Day
  • 1297.16
  • 50 Day
  • 1317.29
  • 100 Day
  • 1351.07
  • 200 Day
  • 1429.84

Glaxosmithkline Pharmaceuticals Resistance and Support

PIVOT
₹1264.66
Resistance
First Resistance 1272.3
Second Resistance 1281.6
Third Resistance 1289.25
RSI 27.09
MFI 44.34
MACD Single Line -11.18
MACD -14.9
Support
First Resistance 1255.35
Second Resistance 1247.7
Third Resistance 1238.41

Glaxosmithkline Pharmaceuticals Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 173,151 16,253,684 93.87
Week 63,601 5,411,194 85.08
1 Month 47,426 3,719,621 78.43
6 Month 69,609 5,144,077 73.9

Glaxosmithkline Pharmaceuticals Result Highlights

GlaxoSmithKline Pharmaceuticals Synopsis

NSE-Medical-Diversified

Glaxosmithkline Phar is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 3217.51 Cr. and Equity Capital is Rs. 169.41 Cr. for the Year ended 31/03/2022. GlaxoSmithKline Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 13/11/1924 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24239MH1924PLC001151 and registration number is 001151.
Market Cap 21,482
Sales 3,235
Shares in Float 4.24
No of funds 201
Yield 2.38
Book Value 7.99
U/D Vol ratio 0.9
LTDebt / Equity
Alpha -0.08
Beta 0.24

GlaxoSmithKline Pharmaceuticals

Owner NameDec-22Sep-22Jun-22Mar-22
Promoters 75%75%75%
Mutual Funds 4.12%3.82%4.06%
Insurance Companies 6.1%6.62%
Foreign Portfolio Investors 2.28%2.17%2.16%
Financial Institutions/ Banks 0.01%0.01%0.02%
Individual Investors 10.56%10.4%10.41%
Others 1.93%1.98%8.35%

GlaxoSmithKline Pharmaceuticals Management

Name Designation
Ms. R S Karnad Chairperson
Mr. Sridhar Venkatesh Managing Director
Dr.(Ms.) S Maheshwari Director
Mr. S Williams Director
Mr. P V Bhide Director
Mr. N Kaviratne Director
Mr. A N Roy Director
Mr. D Sundaram Director
Mr. M Anand Director
Mr. J Chandy Director

Glaxosmithkline Pharmaceuticals Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Glaxosmithkline Pharmaceuticals Corporate Action

Date Purpose Remarks
2023-02-07 Quarterly Results
2022-11-11 Quarterly Results
2022-07-25 Quarterly Results
2022-05-16 Audited Results & Dividend
2022-02-07 Quarterly Results
Date Purpose Remarks
2022-07-08 FINAL Rs.30.00 per share(300%)Dividend
2022-07-08 SPECIAL Rs.60.00 per share(600%)Special Dividend
2021-07-20 FINAL Rs.30.00 per share(300%)Dividend

GlaxoSmithKline Pharmaceuticals MF Shareholding

Name Amount(cr)
ICICI Prudential Bluechip Fund Growth 35049
ICICI Prudential Value Discovery Fund Growth 27515
Aditya Birla Sun Life Tax Relief 96 Pyt of Inc Dis cum Cap Wdrl 13728
SBI Magnum Midcap Fund Regular Growth 8436
ICICI Prudential Large & Mid Cap Fund Growth 6210

GlaxoSmithKline Pharmaceuticals FAQs

What is Share Price of GlaxoSmithKline Pharmaceuticals ?

GlaxoSmithKline Pharmaceuticals share price is ₹1269 As on 30 January, 2023 | 10:41

What is the Market Cap of GlaxoSmithKline Pharmaceuticals ?

The Market Cap of GlaxoSmithKline Pharmaceuticals is ₹21507.8 Cr As on 30 January, 2023 | 10:41

What is the P/E ratio of GlaxoSmithKline Pharmaceuticals ?

The P/E ratio of GlaxoSmithKline Pharmaceuticals is 12.8 As on 30 January, 2023 | 10:41

What is the PB ratio of GlaxoSmithKline Pharmaceuticals ?

The PB ratio of GlaxoSmithKline Pharmaceuticals is 8.1 As on 30 January, 2023 | 10:41

Q2FY23